Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof

作者: Terrance Grant Johns , Antony Wilks Burgess , Llyod J. Old , Andrew Mark Scott

DOI:

关键词:

摘要: The present invention relates to antibodies, particularly antibody 175, and fragments thereof or antibodies derived therefrom, which bind the EGF receptor, amplified overexpressed epidermal growth factor receptor (EGFR) de2-7 EGFR truncation of EGFR. These are useful in diagnosis treatment cancer. Recombinant hybrid having variable region heavy light chain sequence(s) 175 also provided. may be used therapy combination with chemotherapeutics anti-cancer agents and/or other thereof.

参考文章(1,201)
H Mellstedt, Monoclonal antibodies in human cancer. Drugs of Today. ,vol. 39, pp. 1- 16 ,(2003)
Hayman Mj, Enrietto Pj, Cell transformation by the epidermal growth factor receptor and v-erbB. Cancer Cell. ,vol. 3, pp. 302- 307 ,(1991)
Anne-Karina T. Perl, Jay W. Tichelaar, Jeffrey A. Whitsett, Conditional gene expression in the respiratory epithelium of the mouse Transgenic Research. ,vol. 11, pp. 21- 29 ,(2002) , 10.1023/A:1013986627504
V Levin, M D Prados, Biology and treatment of malignant glioma. Seminars in Oncology. ,vol. 27, pp. 1- 10 ,(2000)
Jacqueline S. Biscardi, David A. Tice, Sarah J. Parsons, c-Src, Receptor Tyrosine Kinases, and Human Cancer Advances in Cancer Research. ,vol. 76, pp. 61- 119 ,(1999) , 10.1016/S0065-230X(08)60774-5